Bionoid Pharma Inc. (BINP)

Bionoid Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009
Revenue	0.09	-	-	-	-
Cost of Revenue	0.04	0	0.32	0.25	0.18
Gross Profit	0.05	-0	-0.32	-0.25	-0.18
Selling, General & Admin	0.44	0.45	3.97	3.15	2.61
Research & Development	0	0	0.51	0.48	0.13
Operating Expenses	0.44	0.45	4.48	3.63	2.75
Operating Income	-0.39	-0.45	-4.8	-3.88	-2.93
Interest Expense	-0.07	-0.01	-0.01	-0.02	-0.48
Interest & Investment Income	-	-	-	-	0
Other Non Operating Income (Expenses)	0	-	-	-	-
EBT Excluding Unusual Items	-0.45	-0.46	-4.8	-3.91	-3.41
Impairment of Goodwill	-1.35	-	-	-	-
Asset Writedown	-	-	-0.25	-	-
Other Unusual Items	0.19	0.57	1.1	-	-
Pretax Income	-1.62	0.11	-3.96	-3.91	-3.41
Income Tax Expense	0	0	0	0	0
Net Income	-1.62	0.11	-3.96	-3.91	-3.41
Net Income to Common	-1.62	0.11	-3.96	-3.91	-3.41
Shares Outstanding (Basic)	0	0	0	0	-
Shares Outstanding (Diluted)	0	0	0	0	-
Shares Change (YoY)	101.25%	13.90%	28.63%	-	-
EPS (Basic)	-46.27	6.32	-258.69	-328.60	-
EPS (Diluted)	-46.27	6.32	-258.69	-328.60	-
Free Cash Flow	-0.36	-0.09	-0.92	-1.73	-0.49
Free Cash Flow Per Share	-10.20	-5.38	-60.05	-145.33	-
Gross Margin	51.47%	-	-	-	-
Operating Margin	-421.66%	-	-	-	-
Profit Margin	-1759.14%	-	-	-	-
Free Cash Flow Margin	-387.63%	-	-	-	-
EBITDA	-0.39	-0.45	-4.76	-3.85	-2.89
D&A For EBITDA	0	0	0.03	0.03	0.04
EBIT	-0.39	-0.45	-4.8	-3.88	-2.93
Effective Tax Rate	-	0.72%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.